Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer (GRECO-B)

Guardant Health

Status: Completed

Conditions: Advanced Breast Cancer

Treatments: Diagnostic Test: Guardant360 test

Study type: Observational

Funder types: Industry

Identifiers

NCT04436393

01-BR-003

Details and patient eligibility

About

The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.

Full description

Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing will be approached regarding participation in the study. After being informed about the study and potential risks, all patients providing informed consent and access to their medical records, will provide a list of their health care providers related to their cancer treatment. Data related to their routine clinical care will be abstracted from medical records.

Enrollment: 109 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Adults (18 years of age and older) with a diagnosis of breast cancer
2. Guardant360 test results released to the patient's physician no less than 14 days prior to initial patient contact
3. Patient has previously provided contact information (either email or phone) to Guardant Health
4. Able and willing to complete the electronic informed consent process
5. Must have access to a computer terminal or personal computing device
6. Willingness to consent to the release of medical records

Exclusion criteria

1. Unable to understand English

Trial design

109 participants in 1 patient group

Advanced Breast Cancer

Description:

Patients with diagnosis of advanced breast cancer

Treatment:

Diagnostic Test: Guardant360 test